Q1005 HCPCS Level II code: New technology intraocular lens category 5 as defined in federal register notice

Q1005 is the HCPCS code for “New technology intraocular lens category 5 as defined in federal register notice” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

Q1005

New technology intraocular lens category 5 as defined in federal register notice

Short description: Ntiol category 5

HCPCS · United States

Notes for Q1005

As CMS prints them, with any note Q1005 takes from the headings above it.

Note

CMS processing note 0086: Q1001, Q1002, Q1003, Q1004, AND Q1005 MUST BE BILLED WITH ONE OF THE FOLLOWING PROCEDURE CODES - 66983, 66984, 66985 OR 66986 BY ASC.

Medicare details

The indicators CMS publishes with Q1005 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage: Special coverage instructions apply
Medicare pricing: Other carrier priced
Type of service: Ambulatory surgical center (facility usage for surgical services)
BETOS category: Prosthetic/Orthotic devices
Added: Jul 1, 1999

Where Q1005 sits

1Q codesTemporary codes
2Active code Q1005New technology intraocular lens category 5 as defined in federal register notice

Source and release

Data release: HCPCS Level II · October 2026
Effective date: Oct 1, 2026
Publisher: CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

See Q1005 in the CMS source

Frequently asked questions

What does HCPCS code Q1005 mean?

Q1005 is the HCPCS code for “New technology intraocular lens category 5 as defined in federal register notice” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover Q1005?

CMS lists Q1005’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

All Q codes

Q0517Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days Q0518Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days Q0519Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days Q0520Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days Q0521Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription Q1004New technology intraocular lens category 4 as defined in federal register notice Q2004Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml Q2009Injection, fosphenytoin, 50 mg phenytoin equivalent Q2017Injection, teniposide, 50 mg Q2026Injection, radiesse, 0.1 ml Q2028Injection, sculptra, 0.5 mg Q2034Influenza virus vaccine, split virus, for intramuscular use (agriflu)